Scott Radow
Pulmonary Disease · Richmond, VANPI 1356367171
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 323 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 29 manufacturers, the largest accounting for just 16.4% — the pattern of someone who eats at a lot of different presentations.
Across 323 payments — averaging $15.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$803
- AstraZeneca$680
- Boehringer Ingelheim$550
- Grifols USA, LLC$456
- Genentech USA, Inc.$422
- Mallinckrodt Hospital Products Inc.$344
- plus $2K from 23 others
Across 3 payments — averaging $2176.66 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- GSK$7K
What the payments were for
- Food & beverage$4,897100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 88 | $803 |
| AstraZeneca | 24 | $680 |
| Boehringer Ingelheim | 36 | $550 |
| Grifols USA, LLC | 22 | $456 |
| Genentech USA, Inc. | 35 | $422 |
| Mallinckrodt Hospital Products Inc. | 14 | $344 |
| Novartis | 12 | $175 |
| United Therapeutics Corporation | 9 | $164 |
| Amgen | 9 | $143 |
| Insmed, Inc. | 10 | $135 |
| Sanofi | 8 | $119 |
| Mylan Specialty L.p. | 8 | $112 |
| Regeneron Healthcare Solutions, Inc. | 5 | $98 |
| Sunovion Pharmaceuticals Inc. | 5 | $97 |
| Paratek Pharmaceuticals, Inc. | 6 | $78 |
| Gilead | 5 | $75 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $72 |
| Actelion Pharmaceuticals US, Inc. | 4 | $66 |
| Mallinckrodt Enterprises LLC | 4 | $63 |
| Merck | 3 | $43 |
| Pfizer | 2 | $28 |
| Philips North America LLC | 1 | $25 |
| Teva Pharmaceuticals USA, Inc. | 2 | $25 |
| Advanced Respiratory, Inc | 2 | $24 |
| Bayer | 2 | $24 |
| Baxter Healthcare | 1 | $22 |
| Nabriva Therapeutics, PLC | 1 | $20 |
| Vapotherm Inc | 1 | $19 |
| Inogen, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,897 in reported general payments places this provider in the 60th percentile of 317 pulmonary disease providers in Virginia.
Other pulmonary disease in Richmond
- Sujoy GillRichmond$296K
- Patricia SimeRichmond$113K
- Shilpa JohriRichmond$37K
- Apostolos PerelasRichmond$31K
- John SentzRichmond$20K
- Glenn GiesselRichmond$14K
- Nauman ChaudaryRichmond$13K
- Michael MistrettaRichmond$13K
- Steven NathanFalls Church$1.5M
- Omar MinaiHopewell$1.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.